Target intelligence / Profile preview

LONRF2 pseudogene 3 (LONRF2P3)

Target: LONRF2P3
Molecular classification: Other, pseudogene, pseudogene-derived long non-coding RNA

Overview

LONRF2 pseudogene 3 (LONRF2P3) is a genomic pseudogene related to the LONRF2 (LON peptidase N-terminal domain and ring finger protein 2) gene, which encodes a protein involved in protein quality control and ubiquitin ligase activity[1][5]. LONRF2P3 itself does not encode a protein. Pseudogenes such as LONRF2P3 may sometimes be transcribed into non-coding RNAs (e.g., lncRNAs) that can regulate the expression of their parent or related genes at the RNA level, but there is no evidence or literature describing a functional role, therapeutic relevance, or disease association for LONRF2P3 specifically[2][4].

Biological functions

May play a regulatory role at the RNA level if transcribed (pseudogene-derived lncRNAs can regulate gene expression, typically by competing with their parent gene for regulatory factors such as miRNAs and RNA-binding proteins)Specific biological functions for LONRF2P3 are not established

Disease associations

No direct disease associations reported for LONRF2P3General disease roles for other pseudogenes include modulation of cancer, cell proliferation, and potentially as regulatory RNAs in various pathological processes, but this is not established for LONRF2P3 specifically

Beyond the preview

Go deeper on LONRF2 pseudogene 3 (LONRF2P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LONRF2 pseudogene 3 (LONRF2P3).

Explore the full profile